Investigator Sponsored Studies, Grants and Sponsorships
Vertex Pharmaceuticals offers grants supporting independent research and innovation in cystic fibrosis, pain, kidney, and rare diseases to advance scientific understanding and patient care.
Funder: Vertex Pharmaceuticals
Due Dates: Rolling (most Investigator Sponsored Studies, grants, and sponsorships) | 2026 (next cycle for CF Circle of Care, Research Innovation Awards, and Vertex Innovation Awards)
Funding Amounts: No fixed cap; typical awards vary by program. CF Research Innovation Awards: up to $750,000 (3 years, independent); up to $125,000 (2 years, mentored); Vertex Innovation Awards: up to $750,000/project.
Summary: Vertex supports independent research, education, and community initiatives in cystic fibrosis, pain, kidney diseases, and other serious conditions through grants, studies, and sponsorships.
Key Information: Most programs accept applications year-round; some CF-focused awards open next in 2026.
Description
Vertex Pharmaceuticals offers a comprehensive suite of funding opportunities to support scientific research, medical education, patient advocacy, and community initiatives in areas aligned with their therapeutic focus. These include Investigator Sponsored Studies (ISS), medical and patient education grants, and sponsorships for events and initiatives. Key focus areas are cystic fibrosis, pain (U.S. only), beta thalassemia, sickle cell disease, IgA nephropathy, and related rare diseases. Funding is intended to advance understanding, care, and outcomes for patients with serious diseases.
